Could a geriatric checkup boost quality of life for older cancer survivors?

NCT ID NCT04405115

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study tests whether adding a geriatric assessment visit to the standard survivorship care plan improves quality of life and satisfaction for adults aged 65 and older who have completed chemotherapy with curative intent. Participants receive either the standard care plan alone or the care plan plus a geriatric assessment. The study measures feasibility, retention, and patient satisfaction to see if this extra step is worthwhile.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a survivorship care plan plus a geriatric assessment visit
What this could lead to
If it works, this could point toward a better way to support older adults after cancer treatment, improving their quality of life and satisfaction with care.
What could go wrong
This is a small, early-stage study focused on feasibility, so it may not produce definitive results. The added visit may not significantly improve outcomes over the standard care plan alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Community Cancer Institute

    RECRUITING

    Clovis, California, 93611, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.